Study to Evaluate Xtressé Gummy Supplement in Men With Androgenic Alopecia

Conditions

• Androgenic Alopecia
• Hair Loss/Baldness
• Hair Thinning

Eligibility Criteria

Sex

MALE

Age

18 Years - 65 Years

Healthy Volunteers

Not accepted

Interventions

• Xtressé Hair Growth Gummies — OTHER
  The nutraceutical supplement is powered by proprietary X-3 BioActive Blend and contains plant based extracts and regenerative compounds not commonly found in existing hair supplements. The dosage is 2 gummies taken once per day.
• Placebo Comparator — DIETARY_SUPPLEMENT
  The placebo supplement will contain no active ingredients. Participants will receive 3 month supply 2 times during the study. Participants will take 2 supplements daily.

Study Details

The goal of this study is to determine if Xtresse' gummy is safe and may help regrow hair in men with androgenic alopecia (common pattern hair loss). Forty-eight participants will be randomly assigned to receive either Xtresse' active gummy or placebo. Neither staff not participant will know which treatment is given. The main aims of this trial are: 1. To confirm using photographic analysis, changes in the quality, volume, and thickness of hair. 2. To gauge patient satisfaction with hair changes and application process. 3. Monitor and report any adverse events associated with the daily intake of Xtressé Participants who qualify will complete 3 in-person visits. Participants will be given a 90-day supply of the gummies at visits 1 (after voluntary consent is given) and 2 to cover the 6-month study period. Photographs and scalp analysis will be performed at each visit to measure changes in hair volume, thickness, and growth.

Key Dates

First listed

Jun 9, 2026

Start date

Sep 29, 2026

Status verified

Aug 2026

Primary completion

Apr 30, 2027

Completion

Jun 30, 2027

Study Design

Enrollment

48 participants (estimated)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Arms

• Experimental: Xtressé Nutraceutical Supplement Active
  Xtressé Nutraceutical Supplement 32 participants will be randomized to this group and receive a 90 day supply of the gummy supplement 2 times during the study. Participants will take supplement daily and notate usage in log.
• Placebo Comparator: Placebo
  16 individuals will be randomized to this group and will receive a 90 day supply of the gummy supplement 2 times during the study. Participants will take supplement daily and notate usage in log.

Primary Outcome Measure

Within-subject increase in hair density assessed via Canfield HairMetrix® Phototrichogram Analysis [ Time Frame: From enrollment to the end of treatment at 6 months ]

Central Contacts

• Dr. Matt Leavitt, DO
  321-594-6851
  [email protected]

Locations (2)

Find similar trials in Maitland, FL

Related Studies

• Evaluating the Combined Use of Supplement and Serum in Promoting Hair Growth in Women With Self-perceived Thinning Hair
  Recruiting · The Center for Clinical and Cosmetic Research · Birmingham, Alabama
• Pilot Study to Evaluate the Efficacy and Safety of Xvie Delivered Into the Scalp by Microneedling in Women With Self-perceived Thinning Hair
  Enrolling By Invitation · Restore Biologics Holdings, Inc. dba Xtressé · Maitland, Florida
• Study Evaluating Xtressé Gummy Supplement in Women With Self-Perceived Thinning Hair
  Enrolling By Invitation · Restore Biologics Holdings, Inc. dba Xtressé · Maitland, Florida
• Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic Alopecia
  EARLY_PHASE1 · Not Yet Recruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina